S-Biomedics is Drug Discovery in South Korea that focus on stem cell differentiation business. Founded in 2005. They cover business area such as developer, somatic cell therapy, safe treatment, intractable disease, functionally enhance cell spheroid, technology, cell function enhancement, target embryonic stem cell differentiation, all pluripotent stem cell line, medication, patient, regenerative biomedicine.
2005
( 19 years old in 2024 )
Stem Cell Differentiation
-
4F, Wooil Venture Town Building 28
Seongsui-ro 26-gil, Seongdong-gu, FedEx building
Seoul, 04797
South Korea
Private
developersomatic cell therapysafe treatmentintractable diseasefunctionally enhance cell spheroidtechnologycell function enhancementtarget embryonic stem cell differentiationall pluripotent stem cell linemedicationpatientregenerative biomedicine
* We use standard office opening hours in near S-Biomedics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
S-Biomedics is Drug Discovery business from South Korea that founded in 2005 (19 years old in 2024), S-Biomedics business is focusing on Stem Cell Differentiation.
S-Biomedics headquarter office and corporate office address is located in 4F, Wooil Venture Town Building 28 Seongsui-ro 26-gil, Seongdong-gu, FedEx building Seoul, 04797 South Korea.
S-Biomedics was founded in South Korea.
In 2024, S-Biomedics is currently focus on stem cell differentiation sector.
Above is snippet of Google Trends for "stem cell differentiation" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with S-Biomedics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
